Literature DB >> 1407004

Histamine levels and clonic convulsions of electrically-induced seizure in mice: the effects of alpha-fluoromethylhistidine and metoprine.

H Yokoyama1, K Onodera, K Maeyama, K Yanai, K Iinuma, L Tuomisto, T Watanabe.   

Abstract

The purpose of this study was to investigate the possible role of the central histaminergic neuron system in electrically-induced seizure in mice. For this purpose, we examined the effects of intraperitoneal (i.p.) injections of histaminergic agents, such as L-histidine, metoprine, and alpha-fluoromethylhistidine (FMH), on electrically-induced seizure. L-Histidine decreased the duration of clonic convulsion in electrically-induced seizure, but not affected that of tonic convulsion. This effect of L-histidine was antagonized by pretreatment with FMH, indicating that it was due to histamine formed by decarboxylation of L-histidine in the central nervous system. The anticonvulsive effect of L-histidine was also reduced by the H1-antagonist pyrilamine, but not by the H2-antagonist zolantidine, indicating that the effect on electrically-induced seizure is mediated through central H1-receptors. Metoprine, which increased the histamine levels in the cerebral cortex, diencephalon and midbrain of mice, decreased the duration of clonic convulsions dose-dependently. Conversely, FMH, which decreased the brain histamine levels, increased the duration of clonic convulsions. Good inverse correlations were found between the duration of clonic convulsions and brain histamine levels, especially in the diencephalon: the histamine levels were inversely proportional to the duration of clonic convulsions. No correlation was found between the duration of tonic convulsions and brain histamine levels. These results suggest that the histaminergic neuron system is important in inhibition of the duration of clonic convulsion on electrically induced seizure in mice.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1407004     DOI: 10.1007/bf00167568

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  28 in total

Review 1.  Histaminergic transmission in the mammalian brain.

Authors:  J C Schwartz; J M Arrang; M Garbarg; H Pollard; M Ruat
Journal:  Physiol Rev       Date:  1991-01       Impact factor: 37.312

2.  A facilitation action of reserpine on the central nervous system.

Authors:  G CHEN; C R ENSOR; B BOHNER
Journal:  Proc Soc Exp Biol Med       Date:  1954-07

3.  Studies on the effects of histaminergic agents on seizure susceptibility in mice.

Authors:  M C Gerald; N A Richter
Journal:  Psychopharmacologia       Date:  1976-04-15

4.  Elevation of brain histamine levels by diaminopyrimidine inhibitors of histamine N-methyl transferase.

Authors:  D S Duch; S W Bowers; C A Nichol
Journal:  Biochem Pharmacol       Date:  1978-05-15       Impact factor: 5.858

5.  Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey.

Authors:  M M Mesulam; E J Mufson; A I Levey; B H Wainer
Journal:  J Comp Neurol       Date:  1983-02-20       Impact factor: 3.215

6.  Selective inhibitors of biosynthesis of aminergic neurotransmitters.

Authors:  J Kollonitsch; L M Perkins; A A Patchett; G A Doldouras; S Marburg; D E Duggan; A L Maycock; S D Aster
Journal:  Nature       Date:  1978-08-31       Impact factor: 49.962

7.  In vivo effects of some histamine H1-receptor antagonists on monoamine metabolism in the mouse brain.

Authors:  S Shishido; R Oishi; K Saeki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

8.  Muricidal suppression by histidine and its antagonism by alpha-fluoromethylhistidine in thiamine deficient rats.

Authors:  K Onodera; Y Ogura
Journal:  Yakubutsu Seishin Kodo       Date:  1985-05

9.  Inhibition of histamine synthesis in brain by alpha-fluoromethylhistidine, a new irreversible inhibitor: in vitro and in vivo studies.

Authors:  M Garbarg; G Barbin; E Rodergas; J C Schwartz
Journal:  J Neurochem       Date:  1980-11       Impact factor: 5.372

10.  Effects of histamine and histamine antagonists on the uptake and release of catecholamines and 5-HT in brain synaptosomes.

Authors:  J Tuomisto; L Tuomisto
Journal:  Med Biol       Date:  1980-02
View more
  7 in total

1.  Histaminergic neurons protect the developing hippocampus from kainic acid-induced neuronal damage in an organotypic coculture system.

Authors:  Tiina-Kaisa Kukko-Lukjanov; Sanna Soini; Tomi Taira; Kimmo A Michelsen; Pertti Panula; Irma E Holopainen
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

2.  Histamine and Seizures : Implications for the Treatment of Epilepsy.

Authors:  H Yokoyama; K Iinuma
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

Review 3.  Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives.

Authors:  M Bhowmik; R Khanam; D Vohora
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

4.  Proconvulsive effects of histamine H1-antagonists on electrically-induced seizure in developing mice.

Authors:  H Yokoyama; K Onodera; K Iinuma; T Watanabe
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Histamine H1 antagonists and clinical characteristics of febrile seizures.

Authors:  Mohammed A Zolaly
Journal:  Int J Gen Med       Date:  2012-03-20

Review 6.  Brain Histamine N-Methyltransferase As a Possible Target of Treatment for Methamphetamine Overdose.

Authors:  Junichi Kitanaka; Nobue Kitanaka; F Scott Hall; George R Uhl; Motohiko Takemura
Journal:  Drug Target Insights       Date:  2016-03-02

7.  Antagonism of Histamine H3 receptors Alleviates Pentylenetetrazole-Induced Kindling and Associated Memory Deficits by Mitigating Oxidative Stress, Central Neurotransmitters, and c-Fos Protein Expression in Rats.

Authors:  Alaa Alachkar; Sheikh Azimullah; Mohamed Lotfy; Ernest Adeghate; Shreesh K Ojha; Rami Beiram; Dorota Łażewska; Katarzyna Kieć-Kononowicz; Bassem Sadek
Journal:  Molecules       Date:  2020-03-30       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.